2,3,4,5-Tetramethoxyamphetamine
Jump to navigation
Jump to search
| File:2,3,4,5-tetramethoxyamphetamine.png | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| Chemical and physical data | |
| Formula | C13H19NO4 |
| Molar mass | 253.30 g·mol−1 |
Tetramethoxyamphetamine, or 2,3,4,5-tetramethoxyamphetamine, is a lesser-known psychedelic drug and a substituted Amphetamine. Tetramethoxyamphetamine was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved), the minimum dosage is listed as 50 mg, and the duration unknown. Tetramethoxyamphetamine produces a threshold, mydriasis, and a headache. Very little data exists about its pharmacological properties, metabolism, and toxicity.
External links
Categories:
- Articles with short description
- Pages with broken file links
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Psychedelic phenethylamines